Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetic profile of nicotine following a
single oral administration of three new nicotine lozenge formulations (V0474) in comparison
with two reference products. The clinical and biological safety of V0474 and the lozenge
acceptability will also be assessed.